Back to Results
First PageMeta Content
Arthritis / Rheumatology / Pfizer / Sulfonamides / Celecoxib / Juvenile idiopathic arthritis / Rheumatoid arthritis / Rofecoxib / Valdecoxib / Health / Medicine / COX-2 inhibitors


DEPARTMENT OF HEALTH & HUMAN SERVICES MEMORANDUM Public Health Service
Add to Reading List

Document Date: 2006-11-14 08:23:15


Open Document

File Size: 141,92 KB

Share Result on Facebook

Company

Pfizer / Cox / G.D. Searle LLC / Searle Ltd. / D. / /

Facility

Johns Hopkins Bayview Medical Center / /

IndustryTerm

marketed and investigational human drug products / /

MedicalCondition

rheumatism / arthritis / rheumatoid arthritis / related diseases / osteoarthritis / pain / juvenile rheumatoid arthritis / anti-inflammtory diseases / inflammation / /

Organization

Integrity Staff office of Management Programs office of Management Date DECISION / Johns Hopkins Bayview Medical Center / Arthritis Drugs Advisory Committee / Department of Medicine / Johns Hopkins Arthritis Center / Food and Drug Administration / Arthritis Advisory Committee / Tolino Director / Ethics and Integrity Staff Office / Johns Hopkins University / FDA Advisory Committee / DEPARTMENT OF HEALTH / Advisors Center for Drug Evaluation / /

Person

Igor Cerny / Randall Lutter / Randall Lutt / Vince Tolino / Joan M. Bathon / /

Position

officer / director / Director / Commissioner / director / trustee / appointing official / Commissioner for Policy and Planning / Director / Ethics / Professor of Medicine / and Co-Director of the Division / consultant / Associate Commissioner for Policy / member / Ph. Associate Commissioner for Policy / /

Product

Celebrex / Vioxx / Bextra / COX-2 / /

SocialTag